Catherine A. Blish

28.2k total citations · 3 hit papers
96 papers, 5.2k citations indexed

About

Catherine A. Blish is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Catherine A. Blish has authored 96 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 40 papers in Infectious Diseases and 27 papers in Virology. Recurrent topics in Catherine A. Blish's work include Immune Cell Function and Interaction (45 papers), HIV Research and Treatment (27 papers) and T-cell and B-cell Immunology (18 papers). Catherine A. Blish is often cited by papers focused on Immune Cell Function and Interaction (45 papers), HIV Research and Treatment (27 papers) and T-cell and B-cell Immunology (18 papers). Catherine A. Blish collaborates with scholars based in United States, Kenya and South Africa. Catherine A. Blish's co-authors include Julia L. McKechnie, Miriam Mérad, Akiko Iwasaki, Federica Sallusto, Aaron J. Wilk, Julie Overbaugh, Thanmayi Ranganath, Dara M. Strauss‐Albee, Laura J. Simpson and Arjun Rustagi and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Catherine A. Blish

92 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

2020 915 citations Aaron J. Wilk, Arjun Rustagi et al. Nature Medicine profile →
The immunology and immunopathology of COVID-19

2022 449 citations Catherine A. Blish et al. profile →
Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells

2015 428 citations Catherine A. Blish et al. profile →

Peers

Countries citing papers authored by Catherine A. Blish

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Blish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Blish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Blish more than expected).

Fields of papers citing papers by Catherine A. Blish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Blish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Blish. The network helps show where Catherine A. Blish may publish in the future.

Co-authorship network of co-authors of Catherine A. Blish

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Blish. A scholar is included among the top collaborators of Catherine A. Blish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Blish. Catherine A. Blish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interferon-mediated NK cell activation increases cytolytic activity against T follicular helper cells and limits antibody response to SARS-CoV-2 2025 ·Nature Immunology ·(unknown), (unknown), Madeline J. Lee, Aaron J. Wilk, (unknown), Andra L. Blomkalns, Kari C. Nadeau, Samuel Yang, Angela J. Rogers, Catherine A. Blish	0
2	Single-Cell and Plasma Proteomics Do Not Differentiate Patients With and Without SARS-CoV-2 Antigenemia in Convalescence in a Cohort of 100 Patients 2025 ·Open Forum Infectious Diseases ·(unknown), Zoe Swank, (unknown), (unknown), Phillip Grant, Hector Bonilla, Karen B. Jacobson, Prasanna Jagannathan, Upinder Singh, David R. Walt, Aruna Subramanian, Catherine A. Blish	0
3	Persistence and free chlorine disinfection of human coronaviruses and their surrogates in water 2024 ·Applied and Environmental Microbiology ·Mengyang Zhang, (unknown), William A. Mitch, Catherine A. Blish, Alexandria B. Boehm	2
4	Distinct immune profiles in children living with HIV based on timing and duration of suppressive antiretroviral treatment 2024 ·Virology ·Madeline J. Lee, (unknown), Elena Vendrame, Rosemary Vergara, Thanmayi Ranganath, (unknown), (unknown), Agnes Langat, (unknown), Jillian Neary, Sarah Benki, Dalton Wamalwa, Grace John‐Stewart, Dara A. Lehman, Catherine A. Blish	1
5	Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution 2024 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Philip Grant, Hector Bonilla, Marisa Holubar, Upinder Singh, Karen B. Jacobson, Prasanna Jagannathan, Yvonne Maldonado, Susan Holmes, Aruna Subramanian, Catherine A. Blish	15
6	NK Cell–Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19 2024 ·The Journal of Immunology ·Madeline J. Lee, (unknown), Trisha R. Barnard, (unknown), Nicole H. Tobin, Kathie G. Ferbas, Anne W. Rimoin, Otto O. Yang, Grace M. Aldrovandi, Aaron J. Wilk, Jennifer A. Fulcher, Catherine A. Blish	5
7	The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters 2022 ·PLoS Pathogens ·Timothy D. Carroll, Douglas Fox, Neeltje van Doremalen, (unknown), Mary Kate Morris, Alicia Sotomayor-González, Venice Servellita, Arjun Rustagi, Claude Kwe Yinda, Linda Fritts, Julia R. Port, Zhong-Min Ma, Myndi G. Holbrook, Jonathan E. Schulz, Catherine A. Blish, Carl V. Hanson, Charles Y. Chiu, Vincent J. Munster, Sarah A. Stanley, Christopher J. Miller	19
8	SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages 2022 ·Science Translational Medicine ·Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, Sizun Jiang, (unknown), Arjun Rustagi, Renu Verma, Han Chen, Jason R. Andrews, Kirsten D. Mertz, Alexandar Tzankov, Dan E. Azagury, Jack Boyd, Garry P. Nolan, Christian M. Schürch, Matthias S. Matter, Catherine A. Blish, Tracey McLaughlin	65
9	Association Between SARS-CoV-2 RNAemia and Postacute Sequelae of COVID-19 2021 ·Open Forum Infectious Diseases ·Nikhil Ram-Mohan, David Kim, Angela J. Rogers, Catherine A. Blish, Kari C. Nadeau, Andra L. Blomkalns, Samuel Yang	13
10	Stereotypic Expansion of T Regulatory and Th17 Cells during Infancy Is Disrupted by HIV Exposure and Gut Epithelial Damage 2021 ·The Journal of Immunology ·(unknown), Katie Lennard, (unknown), (unknown), (unknown), Susan Holmes, Catherine A. Blish, Heather B. Jaspan, Clive M. Gray	8
11	SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples 2021 ·Open Forum Infectious Diseases ·Renu Verma, (unknown), Giovanny J. Martínez-Colón, Prasanna Jagannathan, Arjun Rustagi, Julie Parsonnet, Hector Bonilla, Chaitan Khosla, Marisa Holubar, Aruna Subramanian, Upinder Singh, Yvonne Maldonado, Catherine A. Blish, Jason R. Andrews	17
12	Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy 2020 ·Blood Advances ·Aaron J. Wilk, (unknown), Rosemary Vergara, Ole Audun Werner Haabeth, Ronald Levy, Robert M. Waymouth, Paul A. Wender, Catherine A. Blish	58
13	TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells 2020 ·AIDS ·Elena Vendrame, Christof Seiler, Thanmayi Ranganath, Nancy Q. Zhao, Rosemary Vergara, Michel Alary, Annie‐Claude Labbé, Fernand Guédou, Johanne Poudrier, Susan Holmes, Michel Roger, Catherine A. Blish	36
14	Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection 2020 ·AIDS ·Nitya S. Ramadoss, Nancy Q. Zhao, Barbra A. Richardson, Philip Grant, Peter S. Kim, Catherine A. Blish	17
15	A single-cell atlas of the peripheral immune response in patients with severe COVID-19 breakdown → 2020 ·Nature Medicine ·Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, Jonasel Roque, Giovanny J. Martínez-Colón, Julia L. McKechnie, Geoffrey T. Ivison, Thanmayi Ranganath, Rosemary Vergara, Taylor Hollis, Laura J. Simpson, Philip Grant, Aruna Subramanian, Angela J. Rogers, Catherine A. Blish	915
16	Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis 2020 ·JCI Insight ·Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel Roque, (unknown), Thanmayi Ranganath, Philip Grant, Aruna Subramanian, Yael Rosenberg‐Hasson, Holden T. Maecker, Susan Holmes, Joseph E. Levitt, Catherine A. Blish, Angela J. Rogers	179
17	Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy 2014 ·Proceedings of the National Academy of Sciences ·Alexander Kay, Julia Fukuyama, Natali Aziz, Cornelia L. Dekker, Sally Mackey, Gary E. Swan, Mark M. Davis, Susan Holmes, Catherine A. Blish	63
18	Cross-Subtype Neutralization Sensitivity despite Monoclonal Antibody Resistance among Early Subtype A, C, and D Envelope Variants of Human Immunodeficiency Virus Type 1 2009 ·Journal of Virology ·Catherine A. Blish, (unknown), Stephanie Rainwater, (unknown), (unknown), Julie Overbaugh	49
19	Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression 2009 ·Journal of Virology ·Anne Piantadosi, Dana Panteleeff, Catherine A. Blish, Jared M. Baeten, Walter Jaoko, R. Scott McClelland, Julie Overbaugh	135
20	Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses 2008 ·Journal of Virology ·Catherine A. Blish, (unknown), Nina Derby, (unknown), Bhavna Chohan, Barbra A. Richardson, Julie Overbaugh	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact